176 related articles for article (PubMed ID: 23224760)
1. The emergence of HIV-1 primary drug resistance genotypes among treatment-naïve men who have sex with men in high-prevalence areas in China.
Yang J; Xing H; Niu J; Liao L; Ruan Y; He X; Feng Y; Li Z; Shao Y
Arch Virol; 2013 Apr; 158(4):839-44. PubMed ID: 23224760
[TBL] [Abstract][Full Text] [Related]
2. Characterization of HIV-1 subtypes and viral antiretroviral drug resistance in men who have sex with men in Beijing, China.
Zhang X; Li S; Li X; Li X; Xu J; Li D; Ruan Y; Xing H; Zhang X; Shao Y
AIDS; 2007 Dec; 21 Suppl 8():S59-65. PubMed ID: 18172393
[TBL] [Abstract][Full Text] [Related]
3. Treatment-naive individuals are the major source of transmitted HIV-1 drug resistance in men who have sex with men in the Swiss HIV Cohort Study.
Drescher SM; von Wyl V; Yang WL; Böni J; Yerly S; Shah C; Aubert V; Klimkait T; Taffé P; Furrer H; Battegay M; Ambrosioni J; Cavassini M; Bernasconi E; Vernazza PL; Ledergerber B; Günthard HF; Kouyos RD;
Clin Infect Dis; 2014 Jan; 58(2):285-94. PubMed ID: 24145874
[TBL] [Abstract][Full Text] [Related]
4. High burden of transmitted HIV-1 drug resistance in Italian patients carrying F1 subtype.
Franzetti M; Lai A; Simonetti FR; Bozzi G; De Luca A; Micheli V; Meraviglia P; Corsi P; Bagnarelli P; Almi P; Zoncada A; Balotta C
J Antimicrob Chemother; 2012 May; 67(5):1250-3. PubMed ID: 22302564
[TBL] [Abstract][Full Text] [Related]
5. Increase in HIV-1-transmitted drug resistance among ART-naïve youths at the China-Myanmar border during 2009 ~ 2017.
Ding Y; Chen M; Wang J; Yang Y; Feng Y; Wang L; Duan S; Lin Q; Xing H; Ma Y; Han M; Ma L
BMC Infect Dis; 2021 Jan; 21(1):93. PubMed ID: 33478415
[TBL] [Abstract][Full Text] [Related]
6. Increase of RT-related transmitted drug resistance in non-CRF01_AE among HIV type 1-infected men who have sex with men in the 7 cities of China.
Zhao B; Han X; Xu J; Hu Q; Chu Z; Zhang J; Lu L; Wang Z; Fu J; Chen X; Yan H; Zhuang M; Wang L; Sun A; Zhang CM; Shang H
J Acquir Immune Defic Syndr; 2015 Mar; 68(3):250-5. PubMed ID: 25469530
[TBL] [Abstract][Full Text] [Related]
7. Characterization of drug resistance mutations in naïve and ART-treated patients infected with HIV-1 in Yaounde, Cameroon.
Ceccarelli L; Salpini R; Moudourou S; Cento V; Santoro MM; Fokam J; Takou D; Nanfack A; Dori L; Torimiro J; Sarmati L; Andreoni M; Perno CF; Colizzi V; Cappelli G
J Med Virol; 2012 May; 84(5):721-7. PubMed ID: 22431019
[TBL] [Abstract][Full Text] [Related]
8. Prevalence of drug-resistant HIV type 1 at the time of initiation of antiretroviral therapy in Portland, Oregon.
MacVeigh MS; Kosmetatos MK; McDonald JE; Reeder JL; Parrish DA; Young TP
AIDS Res Hum Retroviruses; 2013 Feb; 29(2):337-42. PubMed ID: 22697610
[TBL] [Abstract][Full Text] [Related]
9. Low prevalence of transmitted drug resistance among newly diagnosed HIV-1 patients in Latvia.
Balode D; Westman M; Kolupajeva T; Rozentale B; Albert J
J Med Virol; 2010 Dec; 82(12):2013-8. PubMed ID: 20981787
[TBL] [Abstract][Full Text] [Related]
10. Prevalence of transmitted antiretroviral resistance and distribution of HIV-1 subtypes among patients with recent infection in Catalonia (Spain) between 2003 and 2005.
Romero A; Sued O; Puig T; Esteve A; Pumarola T; Casabona J; González V; Matas L; Tural C; Rodrigo I; Margall N; Domingo P; Casanova A; Ferrer E; Caballero E; Ribera E; Farré J; Puig T; Amengual MJ; Navarro G; Prat JM; Masabeu A; Simó JM; Villaverde CA; Barrufet P; Sauca MG; Ortin X; Ortí A; Navarro R; Euras JM; Vilaró J; Villà MC; Montull S; Vilanova C; Pujol F; Díaz O; Miró JM;
Enferm Infecc Microbiol Clin; 2011; 29(7):482-9. PubMed ID: 21543135
[TBL] [Abstract][Full Text] [Related]
11. Prevalence of transmitted HIV-1 drug resistance in HIV-1-infected patients in Italy: evolution over 12 years and predictors.
Bracciale L; Colafigli M; Zazzi M; Corsi P; Meraviglia P; Micheli V; Maserati R; Gianotti N; Penco G; Setti M; Di Giambenedetto S; Butini L; Vivarelli A; Trezzi M; De Luca A
J Antimicrob Chemother; 2009 Sep; 64(3):607-15. PubMed ID: 19608581
[TBL] [Abstract][Full Text] [Related]
12. Molecular and epidemiological characterization of HIV-1 infection networks involving transmitted drug resistance mutations in Northern Greece.
Skoura L; Metallidis S; Buckton AJ; Mbisa JL; Pilalas D; Papadimitriou E; Papoutsi A; Haidich AB; Chrysanthidis T; Tsachouridou O; Antoniadou ZA; Kollaras P; Nikolaidis P; Malisiovas N
J Antimicrob Chemother; 2011 Dec; 66(12):2831-7. PubMed ID: 21933785
[TBL] [Abstract][Full Text] [Related]
13. Minority HIV-1 resistant variants in recent infection and in patients who failed first-line antiretroviral therapy with no detectable resistance-associated mutations in Thailand.
Le Nguyen H; Pitakpolrat P; Sirivichayakul S; Delaugerre C; Ruxrungtham K
J Med Virol; 2012 May; 84(5):713-20. PubMed ID: 22431018
[TBL] [Abstract][Full Text] [Related]
14. Epidemiological surveillance of HIV-1 transmitted drug resistance among newly diagnosed individuals in Shijiazhuang, northern China, 2014-2015.
Wang X; Liu X; Li F; Zhou H; Li J; Wang Y; Liu L; Liu S; Feng Y; Wang N
PLoS One; 2018; 13(6):e0198005. PubMed ID: 29870534
[TBL] [Abstract][Full Text] [Related]
15. Prevalence of transmitted HIV drug resistance since the availability of highly active antiretroviral therapy.
Russell JS; Chibo D; Kaye MB; Gooey ML; Carolan LA; Papadakis A; Nicholls JA; Birch CJ
Commun Dis Intell Q Rep; 2009 Jun; 33(2):216-20. PubMed ID: 19877541
[TBL] [Abstract][Full Text] [Related]
16. Drug resistance prevalence and HIV-1 variant characterization in the naive and pretreated HIV-1-infected paediatric population in Madrid, Spain.
de Mulder M; Yebra G; Martín L; Prieto L; Mellado MJ; Rojo P; Muñoz-Fernández MÁ; Jiménez de Ory S; Ramos JT; Holguín A;
J Antimicrob Chemother; 2011 Oct; 66(10):2362-71. PubMed ID: 21810838
[TBL] [Abstract][Full Text] [Related]
17. Prevalence of transmitted HIV-1 drug resistance among female sex workers and men who have sex with men in El Salvador, Central America.
Murillo W; Lorenzana de Rivera I; Albert J; Guardado ME; Nieto AI; Paz-Bailey G
J Med Virol; 2012 Oct; 84(10):1514-21. PubMed ID: 22930496
[TBL] [Abstract][Full Text] [Related]
18. Scale-up of antiretroviral treatment in sub-Saharan Africa is accompanied by increasing HIV-1 drug resistance mutations in drug-naive patients.
Aghokeng AF; Kouanfack C; Laurent C; Ebong E; Atem-Tambe A; Butel C; Montavon C; Mpoudi-Ngole E; Delaporte E; Peeters M
AIDS; 2011 Nov; 25(17):2183-8. PubMed ID: 21860346
[TBL] [Abstract][Full Text] [Related]
19. New trends of primary drug resistance among HIV type 1-infected men who have sex with men in Liaoning Province, China.
Zhao B; Han X; Dai D; Liu J; Ding H; Xu J; Chu Z; Bice T; Diao Y; Shang H
AIDS Res Hum Retroviruses; 2011 Oct; 27(10):1047-53. PubMed ID: 21417755
[TBL] [Abstract][Full Text] [Related]
20. Trends in drug resistance prevalence in HIV-1-infected children in Madrid: 1993 to 2010 analysis.
de Mulder M; Yebra G; Navas A; Martin L; de Jose MI; Navarro ML; de Ory SJ; Gonzalez-Granado I; Mellado MJ; Ramos JT; Holguin A
Pediatr Infect Dis J; 2012 Nov; 31(11):e213-21. PubMed ID: 22785049
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]